GlassScriptPhysician profile
Laura Robinette
NPI 1104072693
$15,827.22
in general payments reported to CMS, 2019-2025
22 companies · $677 in 2025
The $677 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $11.39 · 2021: $165 · 2022: $108 · 2023: $419 · 2024: $711 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,782 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.38 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $13,736.01 | 2019-2025 | |
| Viiv Healthcare Company | $352.20 | 2022-2025 | Apretude |
| Pfizer INC. | $275.58 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $267.73 | 2019-2025 | Trintellix |
| Supernus Pharmaceuticals, INC. | $233.71 | 2021-2022 | |
| Novo Nordisk INC | $193.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $107.01 | 2023-2024 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $84.99 | 2024-2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $82.39 | 2019-2025 | Breztri, Airsupra |
| Exact Sciences Corporation | $74.09 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $67.18 | 2023-2024 | Aptima |
| Astellas Pharma US INC | $66.52 | 2023-2024 | Veozah |
| Alk-Abello, INC | $55.35 | 2025 | Neffy |
| Kowa Pharmaceuticals America, INC. | $48.42 | 2024-2025 | Zoryve |
| Currax Pharmaceuticals LLC | $39.92 | 2023-2025 | Nexletol, Contrave |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $37.47 | 2024 | Immunocap |
| Bayer Healthcare Pharmaceuticals INC. | $24.81 | 2025 | |
| Genentech USA, INC. | $21.70 | 2019 | |
| Cranial Technologies, INC | $17.43 | 2025 | Doc Band |
| Melinta Therapeutics, LLC | $15.88 | 2019 | |
| Seqirus USA INC | $14.29 | 2025 | Flucelvax, Fluad |
| Axsome Therapeutics, INC. | $11.28 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Robinette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.